Limited Programs Available! .
Participate Now in This Unique, State-of-the-Art Visiting Professor Clinical Roundtable Tailored to Your Diabetes Clinic!
- Case-based lecture followed by personalized visiting professor clinical consultation to discuss your team’s challenges
- Learn about the physiology of amylin and insulin and their role in glucose regulation, guidelines for initiating pramlintide in type 1 and type 2 diabetes, and practical tips for the successful use of pramlintide
- Visiting professor team meeting format helps you to identify clinical barriers to effective glycemic control in patients on insulin and understand the rationale for using pramlintide to overcome those barriers
- Presented by nationally prominent experts
- No charge to your hospital or to participants
- Complimentary catering/meals provided
- Free CME for participants – Up to 1.0 AMA PRA Category 1 Credit™
CME Planning Committee
Stephen L. Aronoff, MD, Chair
Clinical Associate Professor of Medicine
Department of Endocrinology and Metabolism
University of Texas Southwestern Medical School
Clinical Endocrinologist
Endocrine Associates of Dallas
Director, Research Institute of Dallas
Dallas, Texas
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Division of Endocrinology, Diabetes, Bone and Mineral Disorders
Henry Ford Health System
Detroit, Michigan
Contact us for a complete list of our expert faculty.
To schedule an Endocrinology CME Visiting Professor Clinical Roundtable, call Lori Vartabedian at 866-867-8350, ext. 298 or e-mail lvartabedian@ncme.com.
Limited Programs Available
This program is designed for diabetes clinic treatment teams including endocrinologists, diabetologists, endocrinology fellows, physician assistants, pharmacists, nurses, diabetes educators, and nutritionists.
Learning Objectives
After taking part in this activity, participants should be able to:
- Recognize that postprandial glucose control involves multiple glucoregulatory hormones, including the beta-cell hormone amylin
- Describe the physiologic and clinical benefits of amylin-replacement therapy in insulin-requiring patients with diabetes
- Identify patients who are candidates for amylin-replacement therapy, and develop individualized treatment strategies using this therapy as an adjunct to insulin.
Accreditation and Designation of Credit
The Network for Continuing Medical Education (NCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
